Subtracting Rx Adds To Perrigo OTC Pipeline
Executive Summary
In deal with Altaris Capital, “I don't feel like we got out at any cost,” says Perrigo CEO Murray Kessler. Agreement calls for “a number of mutual long-term relationship components ... including on Rx-to-OTC switches."
You may also be interested in...
It’s Official: Perrigo’s Entirely Consumer Health
"We are now a leading pure-play global consumer self-care company that has significant resources to invest,” says CEO Murray Kessler with Rx business sale closing.
Perrigo Expects Trans-Atlantic Boost: Eliminating Irish Tax Debt, Importing European Brands
In investor conference presentations, CEO Kessler says “we have a very strong case that the way we filed those taxes was correctly and the assessment should be 0,” and bringing its European consumer health brands to the US is “finally starting to really happen.”
Perrigo Offloads LATAM Business In Push To Cut Costs And Improve Margins
Perrigo has struck a deal with Advent International to offload its "sub scale" and margin-dilutive OTC businesses in Mexico and Brazil.